PHILADELPHIA, PA / ACCESS Newswire / February 20, 2025 / Kehoe Law Firm, P.C. is investigating securities claims on behalf of investors of BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ:BIOA) who purchased or acquired BioAge stock pursuant or traceable to the registration statement for its initial public offering ("IPO") which occurred on or about September 26, 2024.
BIOAGE INVESTORS ARE ENCOURAGED TO CONTACT US OR COMPLETE OUR SECURITIES QUESTIONNAIRE TO DISCUSS THEIR RIGHTS WITH AN ATTORNEY.
A class action lawsuit has been filed in federal court alleging violations of federal securities laws on behalf of investors who acquired BioAge stock in connection with the Company's September 2024 IPO.
On or about September 26, 2024, BioAge, "a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases," conducted its IPO, selling 12,650,000 shares of common stock at $18.00 per share.
On December 6, 2024, BioAge announced the discontinuation of its STRIDES Phase 2 study of azelaprag. The company stated that the emerging safety profile of the drug was inconsistent with its goal of a best-in-class oral obesity therapy.
Following this news, BioAge's stock price plummeted $15.44 per share (76.85%), closing at $4.65 per share on December 9, 2024.
BioAge Shareholders: Learn More About the Securities Class Action and Your Legal Options
INVESTORS WHO ACQUIRED THEIR BIOAGE STOCK PURSUANT OR TRACEABLE TO BIOAGE'S IPO ALSO CAN CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION LAWSUIT AND A FREE, NO-OBLIGATION LEGAL EVALUATION.
Investors who purchased BioAge stock pursuant to the Company's IPO have until March 10, 2025 to petition the Court for appointment as lead plaintiff. The Court typically appoints the investor with the largest financial interest who also meets the adequacy and typicality requirements. Investors who wish to discuss their rights or the lead plaintiff process are encouraged to contact our firm.
About Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and corporate misconduct. Our attorneys have served as Lead or Co-Lead Counsel in cases recovering over $10 billion on behalf of institutional and individual investors and consumers.
This press release may constitute attorney advertising.
SOURCE: Kehoe Law Firm, P.C.